Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Daily News

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Todd Neale

June 28, 2024

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Cardiosave IABPs—Yet Again—the Subject of a Class I Recall: FDA

Caitlin E. Cox

August 17, 2023

News Daily News

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Michael O'Riordan

August 10, 2023

News Daily News

Recall for Mislabeled Cartons of Amiodarone, Tranexamic Acid Injections: FDA

Shelley Wood

September 01, 2020

News Daily News

FDA: Class I Recall for Vascular Solutions’ Dual Lumen Catheters

L.A. McKeown

May 01, 2020

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Daily News

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Michael O'Riordan

July 16, 2018

News Daily News

FDA Expands Indications for Two Endovascular Stroke Therapies

Todd Neale

September 06, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

Cook Medical Issues Recall for Beacon Tip Catheters

Shelley Wood

May 04, 2016

Advertisement

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Cardiosave IABPs—Yet Again—the Subject of a Class I Recall: FDA

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Recall for Mislabeled Cartons of Amiodarone, Tranexamic Acid Injections: FDA

FDA: Class I Recall for Vascular Solutions’ Dual Lumen Catheters

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

FDA Expands Indications for Two Endovascular Stroke Therapies

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Cook Medical Issues Recall for Beacon Tip Catheters

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content